Trials / Conditions / Multiple Endocrine Neoplasia Type 2A
Multiple Endocrine Neoplasia Type 2A
4 registered clinical trials studyying Multiple Endocrine Neoplasia Type 2A — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Withdrawn | Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine NCT02831179 | Vanderbilt-Ingram Cancer Center | Phase 1 |
| Recruiting | Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168 | Sanford Health | — |
| Completed | Vandetanib to Treat Children and Adolescents With Medullary Thyroid Cancer NCT00514046 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Completed | Sorafenib Tosylate in Treating Patients With Metastatic, Locally Advanced, or Recurrent Medullary Thyroid Canc NCT00390325 | National Cancer Institute (NCI) | Phase 2 |